Journals / Van Tıp Dergisi / 2007 / Cilt: 14 - Sayı: 3

Clinical approach in malign pleural effusion: Analysis of 49 patients

Malign plevral efüzyonda klinik yaklaşım: 49 hastanın analizi

Pages
74–79
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Decortication can be another option for patients with longer survival expectations.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:It was aimed to discuss effectiveness of treatment modality and complications of malignant pleural effusion.
📊
Key Findings & Data:Results: Thoracenthesis had been applied to 14.28 % of patients with deteriorated general condition and whose life expectancy was short.
💡
Conclusion & Impact:Decortication can be another option for patients with longer survival expectations.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Plörodezis · Geriyedönük çalışma · Plevral efüzyon

Abstract

It was aimed to discuss effectiveness of treatment modality and complications of malignant pleural effusion. Methods: Forty nine patients with malignant pleural effusion were analyzed retrospectively. It was assessed in terms of applied treatment procedures, response to treatment and developed complications. Results: Thoracenthesis had been applied to 14.28 % of patients with deteriorated general condition and whose life expectancy was short. The ratio of patients that had been applied chemical pleurodesis was 61.22%. Chemical agent was applied to 26(86.6%) and 4(13.3%) patients by thoracostomy tube and thoracoscopy, respectively. Permanent catheter and Denver pleuroperitoneal shunt had been applied to 12.24% and 8.1% of patients, respectively. Pleuroectomy had been done in 4.08% of patients. Conclusion: Thoracenthesis should be performed in patients with malignant pleural effusion for diagnosis. Treatment of these patients is not possible only by thoracenthesis and tube thoracostomy. Pleural effusion is usually reoccurred in these patients after awhile. Pleurodesis and another pallative treatment modality should be added to thoracal tube drainage. If lung does not expand, chronic drainage options should be considered. Chronic pleural catheter and pleuroperitoneal shunt are among those options. Decortication can be another option for patients with longer survival expectations.

Özet

Bu çalışmada, malign plevral efüzyonlarda seçilecek tedavi yöntemlerinin etkinliğinin ve komplikasyonlarının tartışılması amaçlandı. Yöntem: Kliniğimizde takip edilen 49 malign plevral efüzyonlu hasta retrospektif olarak incelendi. Hastalara uygulanan tedavi girişimleri, tedaviye alınan yanıtlar ve gelişen komplikasyonlar değerlendirildi. Bulgular: Genel durum iyi olmayan ve kısa yaşam beklentisi olan terminal dönemdeki torasentez yapılan hastaların oranı %14,28 idi. Kimyasal plöredezis uygulanan hastaların oranı %61,22 idi. Kimyasal ajan vakaların 26’sında (%86,6) tüp torakostomi içerisinden, 4’ünde (%13,3) ise torakoskopi yoluyla uygulanmıştı. Kalıcı kateter uygulanan hastaların oranı %12,24 ve Denver plöroperitoneal şant uygulananlar %8,1 idi. Hastaların % 4,08’ine plörektomi yapıldığı tespit edildi. Sonuç: Malign plevral efüzyonu olan hastalarda tanı konulması için torasentez yapılmalıdır. Sadece torasentez veya toraks tüpü drenajı ile tedavileri mümkün değildir. Bu hastaların büyük çoğunluğunda plevral efüzyon kısa sürede tekrarlamaktadır. Toraks tüpü drenajına plöredezis eklenmesi veya başka bir palyatif yöntemin kullanılması gerekmektedir. Akciğer ekspansiyonu sağlanamıyorsa kronik drenaj seçenekleri değerlendirilmelidir. Kronik plevral kateter veya plöroperitoneal şant bu amaçla kullanılabilir. Daha uzun sağkalım beklenen hastalarda dekortikasyon yapılabilir.

🔖

Cite This Article

ÇOBANOĞLU, U. (2007). Clinical approach in malign pleural effusion: Analysis of 49 patients. Van Tıp Dergisi, Cilt: 14 - Sayı: 3, 74–79. https://ajindex.com/articles/334227

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Albertine KH, Wiener-Kronish JP, Staub NC. The structure of the parietal pleura and its relationship to pleural fluid dynamics in sheep. Anat Rec 208–401–9,1984
  2. Sahn SA. Pleural diseases related to metastatic maligancies. Eur Respir J 10:1907–1913,1997 3. Lee Y. Teixeira LR, Devin CJ ve ark. Transforming growth factor-beta 2induces pleurodesis significantly faster than tlac. Am j respir Crit Care 163:640-644, 2001
  3. Sahn SA. Malignant pleural effusions. In: Fishman AP. Ed. Pulmonary Disease and Disorders. 3rd ed. Vol 1:1430-1452,1998
  4. Arbak P, Karacan Ö, Erden F ve ark. A.Ü Tıp Fak.1990-1994 yılları arasında izlenen plevral sıvılı olguların özellikleri. Tüberküloz ve Toraks 46: 256-263, 1998
  5. Loddenkemper R. Management of malignant pleural effusion. Pneumologic 2:120-135, 2005
  6. Zakman G, Lechapt E, Bergot E. Management of malignant pleural effusion. Rev Prat 57(5):513-523, 2007
  7. Sahn SA: Malignant pleural effusions. Clin Chest Med. 6:113, 1985
  8. Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of pleurodesis failure. Chest 117:87-95, 2000
  9. Rodriguez-Panadero F, Lopez-Mejias L. Low glucose and pH levels in malignant effusions: diagnostic significance and prognostic value in respect to pleurodesis. Am Rev Respir Dis 139:663-667, 1989
  10. Cohen RG, DeMeester TR, Lafontaine E. The pleura. In:Sabiston DC, Spencer FC, eds. Surgery of the chest. 6th eds. Philadelphia, W.B. Saunders Company (1):523-575, 1995
  11. Antony VB, Loddenkemper R, Astoul P, Boutin C, Goldstraw P, Hott J, Panadero FR, Sahn SA. Management of malignant pleural effusions. Am J Respir Crit Care Med 162:1987-2001, 2000
  12. Vaz MC, Marchi E, Vargas FS. Pleurodesis technigue and indications. J Bras Pneumol 32(4):347-356, 2006
  13. Lynch TJ.: Management of malignant pleural effusions. Chest 103:385S, 1993
  14. Walker-Renard P, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 120:56-64, 1994
  15. Putnam JB, Garrett LW, Swisher SG, Roth JA, Suell DM, Vaporciyan AA, Snythe WR, Merriman KW, DeFord LL. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg 69:369-375, 2000. 17. 17)Aeleny Y. Talc pleurodesis and acute respiratory distress syndrome. Lancet 369(9572):1494-1496, 2007
  16. Marom EM, Patz EF, Erasmus JJ, et al. Malignant pleural effusions. Treatment with small-bore-catheter thoracostomy and talc pleurodesis. Radiology 210:277-81, 1999
  17. Putnam JB